SHR-9839(sc) for Injection

DRUG2 trials

Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Conditions

Advanced Esophageal Squamous Cell CarcinomaSolid Tumor

Phase 1

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors

RecruitingNCT07229638

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Solid Tumor

Start: 2026-02-27End: 2027-06-01Target: 70Updated: 2026-03-20

Phase 2

A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma

RecruitingNCT07751341

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Esophageal Squamous Cell Carcinoma

Start: 2026-09-07End: 2028-12-01Target: 84Updated: 2026-09-16